(2E)-3-(3-bromophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole, 100mg

2-Bromo-3-chloro-6-hydroxybenzaldehyde, 100mg

Cuba de muestra ROTILABO® con tapa a presión, 300 ml, no estéril, 240 pieza(s)

N,N'-[(1S,2S)-1,2-Diphenyl-1,2-ethanediyl]bis[N'-[3,5-bis(trifluoromethyl)phenyl]thiourea], 97%, 100mg

3-(1H-Benzoimidazol-2-yl)-7-diethylamino-chromen-2-one, 98.0%, 5g

9-Fluorenylmethyl Pentafluorophenyl Carbonate>98.0%(HPLC)1g

(6-AMINOPYRIDIN-3-YL)(2-METHOXYPHENYL)METHANONE, 95.0%, 1g

N-(3-amino-2-methylpropyl)acetamide, 98%, 1g

1-(4-Methoxyphenyl)-4-(4-nitrophenyl)piperazine, 95.0%, 250mg

Emulsión de aceite de silicona H, 5 l

2-Oxa-7-azaspiro[3.5]nonane, 95.0%, 1g

N-(5-Amino-2-fluorophenyl)-2-methylpropanamide, 95.0%, 5g